English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Zendy Plus

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Zendy Tools

Zendy Open

Aims  To investigate long‐term efficacy of cardiac ablation for symptomatic arrhythmia by gathering generic and arrhythmia‐related quality of life data using patient‐reported outcome measures before and after ablation.    Methods  Consecutive patients undergoing cardiac ablation procedures at three sites in the United Kingdom were enrolled (n = 561). Data were collected at baseline, at 8–16 weeks, and 12 months after the ablation with responses from 390 patients received at all three time points. Nonparametric tests were used to identify any changes in patient outcomes due to nonnormal data.    Results  There were significant improvements in symptom severity, impact on life scores, EQ‐5D‐5L indices, and visual analogue score (VAS) scores at pre‐ versus 3 months and at preablation versus 1 year. Impact on life score showed additional improvement at 1 year versus 3 months, while improvements in symptom severity, EQ‐5D‐5L indices, and VAS scores continued to be maintained between 3 months and 1 year.    Conclusion  Cardiac ablation provides patients with arrhythmias relief from symptoms, and results in an improvement in quality of life. Improvements observed at 3 months are maintained at 1 year follow‐up.

Quality of life benefits from arrhythmia ablation: A longitudinal study using the C‐CAP questionnaire and EQ5D